Skip to Main Content

Paper Details

The First 2â¿¿Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
1
2021
Cancer, Chemotherapy-Induced Anemia, Epoetin, anemia, cancer, epoetin, oncologists, patient, patients
Author NameAffiliation
Charles L Bennettthe Hematologic Malignancies Research Institute, the Beckman Research Institute, of the City of Hope Cancer Center
Charles L BennettUniversity of South Carolina
Charles L Bennettthe Hematologic Malignancies Research Institute, the Beckman Research Institute, of the City of Hope Cancer Center
Charles L BennettUniversity of South Carolina
Paul R YarnoldUniversity of South Carolina
Benjamin DjulbegovicBeckman Research Institute
Oliver SartorTulane University School of Medicine
  • 1 - 7

Datasets

Release 1.2